Company profile AIKI
AIkido Pharma Inc
AIkido Pharma Inc. was initially formed in 1967 and is a biotechnology company with a diverse portfolio of small-molecule anti-cancer therapeutics. The Company's platform consists of patented technology from leading universities and researchers and we are currently in the process of developing an innovative therapeutic drug platform through strong partnerships with world renow...ned educational institutions, including The University of Texas at Austin and Wake Forest University. Our diverse pipeline of therapeutics includes therapies for pancreatic cancer, acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL). In addition, we are constantly seeking to grow our pipeline to treat unmet medical needs in oncology. The Company is also developing a broad-spectrum antiviral platform that may potentially inhibit replication of multiple viruses including Influenza virus, SARS-CoV (coronavirus), MERS-CoV, Ebolavirus and Marburg virus.
Show More
There is not enough data for aikido pharma -stock -company to provide analysis
There is not enough data for aikido pharma -stock -company to provide correlation calculation
There is not enough data for aikido pharma -stock -company to provide analysis
Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Useful links and data for AIKI
Company name: AIkido Pharma Inc
Sector: Professional, Scientific, and Technical Services
Company's websiteHyperchartsYahoo FinanceMarketWatchStockTwitsSEC FilingsSwaggyStocksLatest articles
2022-12-28T14:00:00Z
PR Newswire
Dominari Holdings Provides Update on Share Repurchase Program2022-12-22T17:15:11-05:00
SEC
4 Form - Statement of changes in beneficial ownership of securities - Dominari Holdings Inc. (0000012239) (Issuer)2022-12-22T16:45:29-05:00
SEC
8-K Form - Current report, items 5.03, 7.01, and 9.01 - Dominari Holdings Inc. (0000012239) (Filer)2022-12-22T13:00:00Z
PR Newswire
AIkido Pharma Announces Name and Stocker Ticker Symbol Change to Dominari Holdings Inc. (Nasdaq: DOMH)2022-12-21T16:15:23-05:00
SEC
4 Form - Statement of changes in beneficial ownership of securities - AIkido Pharma Inc. (0000012239) (Issuer)2022-12-20T17:26:06-05:00
SEC
4 Form - Statement of changes in beneficial ownership of securities - AIkido Pharma Inc. (0000012239) (Issuer)2022-12-19T09:00:09-05:00
SEC
4 Form - Statement of changes in beneficial ownership of securities - AIkido Pharma Inc. (0000012239) (Issuer)2022-12-16T09:00:11-05:00
SEC
4 Form - Statement of changes in beneficial ownership of securities - AIkido Pharma Inc. (0000012239) (Issuer)2022-12-16T09:00:10-05:00
SEC
4 Form - Statement of changes in beneficial ownership of securities - AIkido Pharma Inc. (0000012239) (Issuer)2022-12-15T09:00:25-05:00
SEC
4 Form - Statement of changes in beneficial ownership of securities - AIkido Pharma Inc. (0000012239) (Issuer)2022-12-15T09:00:24-05:00
SEC
4 Form - Statement of changes in beneficial ownership of securities - AIkido Pharma Inc. (0000012239) (Issuer)2022-12-14T09:00:23-05:00
SEC
4 Form - Statement of changes in beneficial ownership of securities - AIkido Pharma Inc. (0000012239) (Issuer)2022-12-14T09:00:14-05:00
SEC
4 Form - Statement of changes in beneficial ownership of securities - AIkido Pharma Inc. (0000012239) (Issuer)2022-12-13T09:00:19-05:00
SEC
4 Form - Statement of changes in beneficial ownership of securities - AIkido Pharma Inc. (0000012239) (Issuer)2022-12-13T09:00:18-05:00
SEC
4 Form - Statement of changes in beneficial ownership of securities - AIkido Pharma Inc. (0000012239) (Issuer)